{"id":"W2023850571","doi":"10.1038/psp.2013.22","title":"Dose Response and Pharmacokinetics of Tofacitinib (CP‐690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis","year":2013,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Psoriasis; Pharmacokinetics; Clinical trial; Placebo; Population; Pharmacology; Plaque psoriasis; Internal medicine; Covariate; Dosing; Dermatology; Rheumatoid arthritis; Statistics; Pathology; Mathematics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005422346,0.0004005526,0.0007916926,0.0005106262,0.0001163191,0.0005716193,0.000315106,0.0005473989,0.0009103709],"category_scores_gemma":[0.006175464,0.0004911967,0.001325205,0.0004937883,0.0002787898,0.0003935789,0.0002368657,0.00100682,0.0002317553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008857749,"about_ca_system_score_gemma":0.000681238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001219555,"about_ca_topic_score_gemma":0.0008409767,"domain_scores_codex":[0.9980587,0.001389573,0.00004329561,0.000183266,0.0002363733,0.00008874435],"domain_scores_gemma":[0.9977781,0.001310401,0.0005060581,0.0002333082,0.00008426655,0.0000878398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1387316,0.008428815,0.1598618,0.0007164248,0.007026205,0.0005043833,0.0007958864,0.273059,0.2124135,0.002400317,0.002730873,0.1933314],"study_design_scores_gemma":[0.006176187,0.05964742,0.2197139,0.00003977023,0.003416165,0.001131353,0.0001394186,0.6441302,0.05919637,0.002451258,0.003731919,0.0002259722],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890807,0.0007314106,0.008714811,0.0001144582,0.00001111845,0.0001151025,0.0005388747,0.00007955045,0.0006138887],"genre_scores_gemma":[0.9969659,0.0002109013,0.002002232,0.00004622873,0.00001080333,0.00007852366,0.000321614,0.00001722434,0.0003465297],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005422346,"threshold_uncertainty_score":0.02867639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03613601634449804,"score_gpt":0.3093371664949287,"score_spread":0.2732011501504306,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}